Ensysce Biosciences, Inc.
ENSC
$1.59
$0.031.60%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -59.72% | 112.00% | -10.33% | 211.69% | 183.64% |
| Total Receivables | -99.75% | 437.47% | -77.13% | 27.15% | 1,555.34% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.45% | -4.30% | -16.04% | -30.38% | -18.50% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -71.53% | 115.66% | 24.62% | 145.80% | 350.62% |
| Total Current Assets | -67.79% | 114.73% | -6.29% | 133.51% | 229.63% |
|
|
|||||
| Total Current Assets | -67.79% | 114.73% | -6.29% | 133.51% | 229.63% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -56.63% | -12.80% | -44.15% | -39.74% | -36.17% |
| Total Assets | -66.12% | 99.40% | -9.11% | 106.68% | 191.57% |
|
|
|||||
| Total Accounts Payable | -76.44% | 116.35% | -37.32% | -29.90% | 114.71% |
| Total Accrued Expenses | 225.19% | 182.47% | 117.56% | 1.14% | -41.22% |
| Short-term Debt | 0.13% | -6.60% | 4.63% | -64.70% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -17.74% | 92.33% | 7.65% | -33.78% | 37.99% |
|
|
|||||
| Total Current Liabilities | -17.74% | 92.33% | 7.65% | -33.78% | 37.99% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 0.13% | -6.60% | 4.63% | -64.70% | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -100.00% | -89.58% | 648.28% | -61.74% | -89.51% |
| Total Liabilities | -17.83% | 91.00% | 14.38% | -34.00% | 36.10% |
|
|
|||||
| Common Stock & APIC | 3.96% | 6.35% | 4.76% | 9.91% | 11.17% |
| Retained Earnings | -8.71% | -5.20% | -5.47% | -6.57% | -6.71% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -82.58% | 87.46% | -18.67% | 1,248.47% | 365.17% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -82.58% | 87.46% | -18.67% | 1,248.47% | 365.17% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -0.03% | -0.03% | 0.00% | -0.03% | -0.34% |
| Total Equity | -86.71% | 106.87% | -20.47% | 618.95% | 468.34% |
|
|
|||||